The University of Chicago Header Logo

Connection

Rajat Thawani to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications Rajat Thawani has written about Poly(ADP-ribose) Polymerase Inhibitors.
Rajat Thawani
Connection Strength
0.879
Poly(ADP-ribose) Polymerase Inhibitors
  1. Combining PARP Inhibitor With Immunotherapy-Does the Promise of Preclinical Data Translate to Clinic? JAMA Oncol. 2023 01 01; 9(1):25-27.
    View in: PubMed
    Score: 0.827
  2. Combining Poly (ADP-Ribose) Polymerase (PARP) Inhibitors with Chemotherapeutic Agents: Promise and Challenges. Cancer Treat Res. 2023; 186:143-170.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.